HIV-associated executive dysfunction in the era of modern antiretroviral therapy: A systematic review and meta-analysis
- 9 July 2017
- journal article
- review article
- Published by Taylor & Francis in Journal of Clinical and Experimental Neuropsychology
- Vol. 40 (4) , 357-376
Abstract
Objective: While some reports suggest that HIV+ individuals continue to display executive function (EF) impairment in the era of cART, findings have been contradictory and appear to differ based on the aspect of EF being measured. To improve the understanding of how discrete executive abilities may be differentially affected or spared in the context of HIV infection, we conducted a systematic review and meta-analysis to (a) determine whether and to what extent HIV+ adults experience deficits in EFs, and (b) understand how demographic and clinical characteristics may modify the associations between HIV infection and executive abilities. Method: Studies comparing HIV+ and HIV-uninfected groups on measures of working memory, set-shifting, inhibition, decision-making, and apathy between 2000 and 2017 were identified from three databases. Effect sizes (Cohen’s d) were calculated using inverse variance weighted random effects models. Meta-regression was used to examine the moderating effect of demographic and clinical variables. Results: Thirty-seven studies (n = 3935 HIV+; n = 2483 HIV-uninfected) were included in the meta-analysis. Pooled effect sizes for deficits associated with HIV infection were small for domains of set-shifting (d = −0.34, 95% CI [−0.47, −0.20]) and inhibition (d = −0.31, 95% CI [−0.40, −0.21]), somewhat larger for measures of decision-making (d = −0.41, 95% CI [−0.53, −0.28]) and working memory (d = −0.42, 95% CI [−0.59, −0.29]), and largest for apathy (d = −0.87, 95% CI [−1.09, −0.66]). Meta-regression demonstrated that age, sex, education, current CD4 count, and substance dependence differentially moderated the effects of HIV infection on specific EFs. However, lower nadir CD4 count was the only variable associated with greater deficits in nearly all EF domains. Conclusions: Our results suggest that discrete domains of EF may be differentially affected by HIV infection and moderating demographic and clinical variables. These findings have implications for the development of targeted cognitive remediation strategies.Keywords
Funding Information
- National Institute of Mental Health (R25 MH080663)
- National Institute on Drug Abuse (P50 DA26306)
This publication has 114 references indexed in Scilit:
- Impact of apolipoprotein E ε4 and HIV on cognition and brain atrophy: Antagonistic pleiotropy and premature brain agingNeuroImage, 2011
- Plasma cytokine concentrations associated with HIV/hepatitis C coinfection are related to attention, executive and psychomotor functioningJournal of Neuroimmunology, 2011
- HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictorsJournal of NeuroVirology, 2010
- Brain metabolism and cognitive impairment in HIV infection: a 3-T magnetic resonance spectroscopy studyMagnetic Resonance Imaging, 2010
- Neurocognitive correlates of alexithymia in asymptomatic individuals with HIVNeuropsychologia, 2010
- White matter tracts associated with set-shifting in healthy agingNeuropsychologia, 2009
- Increased Accumulation of Intraneuronal Amyloid β in HIV-Infected PatientsJournal of Neuroimmune Pharmacology, 2009
- Decreased brain dopamine transporters are related to cognitive deficits in HIV patients with or without cocaine abuseNeuroImage, 2008
- How should meta‐regression analyses be undertaken and interpreted?Statistics in Medicine, 2002
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002